SciELO - Scientific Electronic Library Online

 
vol.62 número3HeberFERON en el tratamiento del carcinoma basoescamoso índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Medicina

versión On-line ISSN 1561-302X

Resumen

ESCALONA GONZALEZ, Sergio Orlando; GONZALEZ MILAN, Zoraida Caridad  y  BORRERO CELLES, Omar. Exacerbated Chronic Kidney Disease as a Cause of Mortality in a Patient with COVID-19. Rev. Cuban de Med [online]. 2023, vol.62, n.3  Epub 01-Sep-2023. ISSN 1561-302X.

Introduction:

SARS-CoV-2 infection in patients with chronic kidney disease is associated with a long hospital stay, the appearance of complications and mortality.

Objective:

To describe the clinical case of a patient with exacerbated chronic kidney disease as a cause of mortality in the presence of COVID-19 infection.

Clinical case:

A 69-year-old male patient with a history of stage 3a chronic kidney disease who was admitted to a hospital with a diagnosis of COVID-19 and who during his stay presented elevated serum creatinine levels with the subsequent development of acute kidney injury. After five hemodialysis sessions, the patient's general condition improved and the creatinine levels partially decreased. Despite clinical improvement, the patient progressed to the last stage of chronic kidney disease. After three weeks under chronic hemodialytic therapy, the patient died due to ST-segment elevation acute coronary syndrome.

Conclusions:

The prognosis of patients with kidney damage who develop COVID-19 is unfavorable. SARS-CoV-2 infection favors progression to the final stages of chronic kidney disease with an increased risk of mortality.

Palabras clave : chronic kidney disease; SARS-CoV-2; COVID-19; acute kidney failure.

        · resumen en Español     · texto en Español     · Español ( pdf )